The assessment of effectiveness and safety of Nozovent Anti-Snoring Spray for snore patients

The assessment of effectiveness and safety of Nozovent Anti-Snoring Spray for snore patients - The assessment of effectiveness and safety of Nozovent Anti-Snoring Spray for snore patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010713

Enrollment

Registered

2013-05-14

Start date

2012-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

snoring

Interventions

Before sleep, Anti-Snoring Spray should be used in the next procedure. 1)The bottle should be shaken carefully before being used. 2)Tip head backwards and spray two times against the upper side of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: simple snorer or OSAS patients 20 years old or older

Exclusion criteria

Exclusion criteria: The patients who has an allergy against cooking oil, those with the severe complication of respiratory or heart disease, those who are pregnant or lactating, those who are receiving another clinical trail, and those who had received other clinical trail within 4 month before are excluded.

Design outcomes

Primary

Measure	Time frame
Snoring sounds (intensity, fundamental frequency, frequency spectrums) latency total snore time	—

Secondary

Measure	Time frame
patients' subjective evaluation respiratory parameters sleep quality	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026